Sakurasaku Plus
7097
Timee
215A
Wintest
6721
Heartseed
219A
Raksul
4384
JP Stock MarketDetailed Quotes
4564 OncoTherapy Science
- 31
- 00.00%
20min DelayMarket Closed Dec 13 15:30 JST
8.42BMarket Cap-5.12P/E (Static)
33High30Low7.32MVolume31Open31Pre Close230.05MTurnover6452wk High3.08%Turnover Ratio271.64MShares1552wk Low-4.81EPS TTM7.37BFloat Cap863Historical HighLossP/E (Static)237.68MShs Float15Historical Low-6.05EPS LYR9.68%Amplitude--Dividend TTM8.42P/B100Lot Size--Div YieldTTM
About OncoTherapy Science Company
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
Company Profile
Symbol4564
Company NameOncoTherapy Science
Founded2001-04-06
MarketTSE Growth
Employees54
Fiscal Year Ends03-31
Address11th Floor, Kanagawa Science Park R&D 3-2-1 Sakado
Zip Code210-0005
Phone044-201-6429
Websitewww.oncotherapy.co.jp
Company Executives
- Name
- Position
- Salary
- Junichi Shimada
- President and Chief Executive Officer
- --
- Paku zai Ken
- Chief Scientific Officer and Director of Management Division
- --
- Toshio Kato
- Chairman of the Board
- --
- Yuichi Komine
- Independent Director
- --
- Yoshio Mitsuki
- Independent Director
- --